Study Stopped
PI is away, will hopefully perform the study at another institution.
The Use of Ultrasound to Quantify Muscle Overlying the Carpal Tunnel
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
Carpal tunnel syndrome (CTS) is a common condition that still lacks a reliable, objective screening test. Many anatomical aspects of the syndrome have been studied including the dimensions of the carpal tunnel and shape of the nerve within the tunnel. The investigators have observed varying amounts of muscle overlying the carpal tunnel in patients undergoing surgery for the condition. Assuming that this muscle may have a dynamic role in the development of the condition, the investigators attempted to quantify this muscle using ultrasound (US). The purpose of this study was to devise a technique to evaluate the amount of muscle overlying the carpal tunnel. The hypothesis is that patients with carpal tunnel syndrome will have significantly more muscle overlying the carpal tunnel than individuals without carpal tunnel syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2015
CompletedFirst Posted
Study publicly available on registry
February 17, 2016
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedJanuary 25, 2018
July 1, 2015
2 years
August 16, 2015
January 24, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
amount-depth of muscle overlying the carpal tunnel
As determined by ultrasound
2 years
Study Arms (2)
carpal tunnel syndrome
No intervention
normals
no intervention
Eligibility Criteria
Patients with the diagnosis of CTS and those without
You may qualify if:
- The diagnosis of CTS will include signs and symptoms of CTS: nighttime numbness and tingling or numbness and tingling in a median nerve distribution with a positive phalen or tinel or forearm compression test as well as a nerve conduction test and electromyography (NCT and EMG) that is positive for CTS.
- The normal subjects: individuals that do not have any signs and or symptoms of CTS.
You may not qualify if:
- Patients or individuals that have a known history of peripheral neuropathy or other condition in the hand including recent significant trauma.
- Patients with incomplete or unclear evaluation and tests.
- Individuals unwilling to sign a consent form to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2015
First Posted
February 17, 2016
Study Start
July 1, 2016
Primary Completion
July 1, 2018
Study Completion
July 1, 2018
Last Updated
January 25, 2018
Record last verified: 2015-07